This review delineates the trajectory of milestone clinical trials, including RV144, the HVTN series, and the AMP studies, to systematically summarize advancements in assessing both humoral and cellular immunity, and highlights a pivotal transition in evaluative logic.
Hang Yu, Xi Wu, Ting-Ting Li et al.· Emerging Microbes and Infect...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.